About Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Charite University, Berlin, Germany
3
Janssen Research & Development, LLC
3
North Eastern German Society of Gynaecological Oncology
3
Actelion
2
German Heart Institute
2
Gilead Sciences
2
Impulse Dynamics
2
4SC AG
1
Banyan Biomarkers, Inc
1
Bristol-Myers Squibb
1
Chimerix
1
Clinical Trials at Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
During the past decade, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 10 clinical trials were completed, i.e. on
average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
2009-03-01
2011-03-01
Completed
34
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
2010-02-01
2011-01-01
Terminated
8
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
2010-03-01
2014-08-01
Completed
2,198
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
2010-07-01
Recruiting
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
2011-08-01
2015-05-01
Completed
61
GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection
2011-09-01
2013-07-01
Completed
170
Studies Investigating Co-morbidities Aggravating Heart Failure
2010-03-01
2016-07-01
Completed
1,600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" #1 sponsor was "Charite University, Berlin, Germany" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "North Eastern German Society of Gynaecological Oncology" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "German Heart Institute"
with 2 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum"
#1 collaborator was "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 2 trials as a collaborator, "ALL SCTped Forum" with 1 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were
collaborators in the rest 42 trials.
Clinical Trials Conditions at Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
According to Clinical.Site data, the most researched conditions in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are
"Heart Failure" (3 trials), "Ovarian Cancer" (3 trials), "Crohn Disease" (2 trials), "Fallopian Tube Cancer" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" in a lesser frequency.
Clinical Trials Intervention Types at Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Most popular intervention types in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are "Drug" (22 trials), "Device" (7 trials), "Other" (6 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ustekinumab" (3 trials), "Fludarabine" (2 trials), "Macitentan" (2 trials) and "ABSORB Scaffold" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
The vast majority of trials in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are
35 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Currently, there are NaN active trials in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum".
2 are not yet recruiting,
13 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 6 trials that are defined as “Not Applicable".